Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

V800245

Sigma-Aldrich

Magnesium sulfate heptahydrate

AR, ≥99.5%

Synonym(s):

Epsom salts

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
MgSO4 · 7H2O
CAS Number:
10034-99-8
Molecular Weight:
246.47
EC Number:
231-298-2
MDL number:
MFCD00149785
UNSPSC Code:
12352302
PubChem Substance ID:
329829246
grade:
AR
form:
crystalline powder
Product V800245 is not currently sold in your country. Contact Technical Service

grade

AR

vapor density

<0.01 (vs air)

vapor pressure

<0.1 mmHg ( 20 °C)

product line

Vetec™

Assay

≥99.5%

form

crystalline powder

pH

5.0-8.2 (5% in water)

cation traces

Fe: ≤0.0005%
heavy metals (as Pb): ≤0.001%

SMILES string

O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O

InChI

1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2

InChI key

WRUGWIBCXHJTDG-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

V800245-500G:4548173324890
V800245-BULK:
V800245-6X500G:
V800245-VAR:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BGBC1046
BGBB9555

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
Chris Chin
Artificial organs, 37(1), 100-102 (2013-01-12)
Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and
A P Morrison et al.
British journal of anaesthesia, 110(5), 702-712 (2013-03-28)
Spinal anaesthesia is the primary anaesthetic technique for many types of surgery. Adjuncts to the local anaesthetics (LA) used in spinal anaesthesia can exhibit undesirable side-effects, limiting their use, but magnesium may have advantages in this respect. We sought randomized
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
Oluwakemi Badaki-Makun et al.
Pediatric blood & cancer, 61(6), 1049-1054 (2014-01-21)
Multiple recent Sickle Cell Disease studies have been terminated due to poor enrollment. We developed methods to overcome past barriers and utilized these to study the efficacy and safety of intravenous magnesium for vaso-occlusive crisis (VOC). We describe the methods
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service